Published ahead of print on December 9, 2005, doi:10.1165/rcmb.2005-0170OC
American Journal of Respiratory Cell and Molecular Biology. Vol. 34, pp. 399-409, 2006
© 2006 American Thoracic Society DOI: 10.1165/rcmb.2005-0170OC
Apoptosis of Airway Epithelial Cells
Human Serum Sensitive Induction by the Cathelicidin LL-37
Y. Elaine Lau,
Dawn M. E. Bowdish,
Celine Cosseau,
Robert E. W. Hancock and
Donald J. Davidson*
Department of Microbiology and Immunology, University of British Columbia, Vancouver, British Columbia, Canada
Correspondence and requests for reprints should be addressed to Dr. R. E. W. Hancock, Centre for Microbial Diseases and Immunity Research, Room 232, 2259 Lower Mall Research Station, University of British Columbia, Vancouver, BC, V6T 1Z4 Canada. E-mail: bob{at}cmdr.ubc.ca
LL-37 is a human cationic host defense peptide that is present in the specific granules of neutrophils, produced by epithelial cells from a variety of tissues, and is upregulated during inflammation, infection, and injury. It has been proposed to have a variety of antimicrobial functions, including both direct antimicrobial activity and immunomodulatory functions. Using the TUNEL assay it was demonstrated that LL-37 induced apoptosis in vitro in the A549 human lung and 16HBE4o- human airway epithelial cell lines, and in vivo in the murine airway. Peptide-induced apoptosis in vitro involved the activation of caspase pathways and was substantially inhibited by an inhibitor of caspase 3. Apoptosis was also inhibited by human serum, but not fetal bovine serum. Similarly, human but not fetal bovine serum inhibited the cellular internalization of LL-37 and the production of IL-8 in response to LL-37 treatment of epithelial cells. The protective effects of human serum were also observed with high-density lipoproteins but not by the core peptide apolipoprotein A1, providing one possible mechanism of human serum inhibition of apoptosis. We propose that LL-37induced apoptosis of epithelial cells at low serum tissue sites may have a protective role against bacterial infection.
Key Words: apoptosis cathelicidin epithelial cells host defense peptide LL-37
This article has been cited by other articles:

|
 |

|
 |
 
H.-N. Li, P. G. Barlow, J. Bylund, A. Mackellar, A. Bjorstad, J. Conlon, P. S. Hiemstra, C. Haslett, M. Gray, A. J. Simpson, et al.
Secondary necrosis of apoptotic neutrophils induced by the human cathelicidin LL-37 is not proinflammatory to phagocytosing macrophages
J. Leukoc. Biol.,
October 1, 2009;
86(4):
891 - 902.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Mookherjee, D. N. D. Lippert, P. Hamill, R. Falsafi, A. Nijnik, J. Kindrachuk, J. Pistolic, J. Gardy, P. Miri, M. Naseer, et al.
Intracellular Receptor for Human Host Defense Peptide LL-37 in Monocytes
J. Immunol.,
August 15, 2009;
183(4):
2688 - 2696.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Chakraborty, P. C. Maity, A. K. Sil, Y. Takeda, and S. Das
cAMP Stringently Regulates Human Cathelicidin Antimicrobial Peptide Expression in the Mucosal Epithelial Cells by Activating cAMP-response Element-binding Protein, AP-1, and Inducible cAMP Early Repressor
J. Biol. Chem.,
August 14, 2009;
284(33):
21810 - 21827.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. S. Mader, N. Mookherjee, R. E.W. Hancock, and R. C. Bleackley
The Human Host Defense Peptide LL-37 Induces Apoptosis in a Calpain- and Apoptosis-Inducing Factor-Dependent Manner Involving Bax Activity
Mol. Cancer Res.,
May 1, 2009;
7(5):
689 - 702.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Bjorstad, G. Askarieh, K. L. Brown, K. Christenson, H. Forsman, K. Onnheim, H.-N. Li, S. Teneberg, O. Maier, D. Hoekstra, et al.
The Host Defense Peptide LL-37 Selectively Permeabilizes Apoptotic Leukocytes
Antimicrob. Agents Chemother.,
March 1, 2009;
53(3):
1027 - 1038.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Zhang, G. Cherryholmes, and J. E. Shively
Neutrophil secondary necrosis is induced by LL-37 derived from cathelicidin
J. Leukoc. Biol.,
September 1, 2008;
84(3):
780 - 788.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Bozue, K. L. Moody, C. K. Cote, B. G. Stiles, A. M. Friedlander, S. L. Welkos, and M. L. Hale
Bacillus anthracis Spores of the bclA Mutant Exhibit Increased Adherence to Epithelial Cells, Fibroblasts, and Endothelial Cells but Not to Macrophages
Infect. Immun.,
September 1, 2007;
75(9):
4498 - 4505.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. G. Barlow, Y. Li, T. S. Wilkinson, D. M. E. Bowdish, Y. E. Lau, C. Cosseau, C. Haslett, A. J. Simpson, R. E. W. Hancock, and D. J. Davidson
The human cationic host defense peptide LL-37 mediates contrasting effects on apoptotic pathways in different primary cells of the innate immune system
J. Leukoc. Biol.,
September 1, 2006;
80(3):
509 - 520.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Pochet, S. Tandel, S. Querriere, M. Tre-Hardy, M. Garcia-Marcos, M. De Lorenzi, M. Vandenbranden, A. Marino, M. Devleeschouwer, and J.-P. Dehaye
Modulation by LL-37 of the Responses of Salivary Glands to Purinergic Agonists
Mol. Pharmacol.,
June 1, 2006;
69(6):
2037 - 2046.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2006 American Thoracic Society.
|
|
|